Cite
HARVARD Citation
Lee, H. et al. (2020). Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase. Alimentary pharmacology & therapeutics. 52 (1), pp. 196-204. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, H. et al. (2020). Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase. Alimentary pharmacology & therapeutics. 52 (1), pp. 196-204. [Online].